Rare diseases
Investigational molecules
Locations
Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
GermanyStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
GermanyStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
GermanyLong-term safety and effectiveness study of verekitug injections in adults with severe asthma who completed the VALIANT trial
GermanyLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
GermanyStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
GermanyStudy of NT 201 compared to placebo in adults with moderate to severe platysma prominence
GermanyComparison of linaprazan glurate versus lansoprazole for healing of erosive esophagitis in adults with gastroesophageal reflux disease
GermanyStudy of Ruxolitinib Cream for Children and Adolescents Ages 6-17 with Moderate Atopic Dermatitis Who Did Not Respond Well to Standard Treatments
GermanyStudy of Rimegepant for Prevention of Menstrual Migraine in Women Aged 18-45 Years
GermanyStudy of Orforglipron for Weight Management in People with Obesity or Overweight, With or Without Type 2 Diabetes
GermanyEvaluation of Ziltivekimab in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
